Amid expansion push, Evonik opens new German lipid manufacturing plant,As Evonik aims to grow...
facilities
UK health service opens facility to develop and produce cell and gene therapies,The National...
Amid Novartis spinoff efforts, Sandoz pledges $400M for biosimilar manufacturing in Slovenia,Sandoz is in...
PCI Pharma unveils plans for $50M expansion at Illinois injectables site,PCI Pharma Services, a...
Formulated Solutions to pump $44M into recently acquired plant, create 524 jobs,Formulated Solutions will...
Cipla facility hit with scathing FDA report detailing shoddy record-keeping, power outages and more,Cipla has...
Whole Foods, Other Grocery Stores Are Hot Property,A deal to acquire a shopping complex...
Barney Frank Pushed to Ease Financial Regulations After Joining Signature Bank Board,The former congressman...
13 hospitals closing departments or ending services,Here are 10 healthcare organizations have recently closed...
Wockhardt looks to trim $12M by restructuring US business, shuttering Illinois plant,Wockhardt plans to...
Freshly minted Actylis revs up work at new drug ingredients plant in Oregon,Recently rebranded...
Moderna picks Oxfordshire for future UK manufacturing and R&D site,On a quest to grow...
As Sanofi contract wind-down prompts layoffs in Boston, Resilience is hiring elsewhere: CEO,A round...
After layoffs and R&D pivot, cash-strapped VBL sells gene therapy manufacturing plant,After a staff...
National Resilience sells Massachusetts manufacturing plant for $125M but plans to lease it back,National...
Lonza opens US lab as part of early development services expansion,Lonza is opening a...
Genentech plugs $450M into next-gen biologics plant in California, where it'll hire 150,Genentech is...
With COVID vaccine on the way, Daiichi Sankyo builds Japan's first mRNA plant: report,Less...
Genentech's California biologics facility will support launches in cancer, neuroscience and more: exec,Genentech is...
Piramal gets FDA resolution at Kentucky plant as it begins production in Michigan,After being...
